Friday, 1 May 2020

Valneva and Pfizer Collaboration to Co-Develop and Commercialize Lyme Disease Vaccine , VLA15

Valneva SE a specialty vaccine company, and Pfizer Inc. announced a collaboration to develop and commercialize Valneva’s Lyme disease vaccine candidate VLA15, which is currently in Phase 2 clinical studies.



source https://www.pharmatutor.org/pharma-news/2020/valneva-and-pfizer-collaboration-to-co-develop-and-commercialize-lyme-disease-vaccine-vla15
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Pharmaceutical jobs for MPharm / MSc / BPharm or BSc - DPharm or PharmD and PhD

  Openings for Pharmacists under the National Health Mission Degree or Diploma in Pharmacy (50%) & Registration in CG Pharmacy Registrat...